 EWING, N.J., May 03, 2021 GLOBE NEWSWIRE -- Antares Pharma, Inc. NASDAQ: ATRS the Company, a specialty pharmaceutical company, today announced that data highlighting the therapeutic potential of subcutaneous testosterone enanthate in younger hypogonadal populations was presented in a poster presentation at the Pediatric Endocrine Society PES 2021 Virtual Annual Meeting on April 30 May 3, 2021. 